Skip to content
TrialScanner

NCT03134352

Study to Evaluate the Efficacy and Safety of ZL-3101 in Subjects With Subacute Eczema

Phase 2CompletedZLABLead

Registry record

Lead sponsor
Zai Lab Pty. Ltd.
Conditions
Eczema
Primary completion
May 25, 2018Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03134352 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03134352: Study to Evaluate the... | TrialScanner